| Jessica Emma Miller, CRNP | |
|
925 Bishop Walsh Rd, Cumberland, MD 21502-1845 | |
| (240) 362-7025 | |
| (240) 362-7064 |
| Full Name | Jessica Emma Miller |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 925 Bishop Walsh Rd, Cumberland, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174125991 | NPI | - | NPPES |
| 1417460619 | Other | MD | TYPE 2 NPI GROUP |
| 1669037008 | Other | MD | TYPE 2 NPI GROUP |
| 392004600 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R196698 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proactive Pain And Neurology Llc | 1355609355 | 5 |
News Archive
The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million that could help deliver a range of new innovative therapies for a host of debilitating conditions.
...may soon be available in over-the-counter gels and strips, according to a dental researcher who shared his team's latest findings today at the American Dental Association's national media conference.
Today, The Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a powerful demonstration of collective standing in the health care community, more than 40 organizations gathered on Capitol Hill to issue a call to action in reducing sudden cardiac arrest (SCA) deaths.
› Verified 5 days ago
| Entity Name | Proactive Pain And Neurology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417460619 PECOS PAC ID: 1355609355 Enrollment ID: O20171221000314 |
News Archive
The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million that could help deliver a range of new innovative therapies for a host of debilitating conditions.
...may soon be available in over-the-counter gels and strips, according to a dental researcher who shared his team's latest findings today at the American Dental Association's national media conference.
Today, The Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a powerful demonstration of collective standing in the health care community, more than 40 organizations gathered on Capitol Hill to issue a call to action in reducing sudden cardiac arrest (SCA) deaths.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Emma Miller, CRNP 19305 Upper Consol Rd Nw, Frostburg, MD 21532-2185 Ph: (717) 375-8931 | Jessica Emma Miller, CRNP 925 Bishop Walsh Rd, Cumberland, MD 21502-1845 Ph: (240) 362-7025 |
News Archive
The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million that could help deliver a range of new innovative therapies for a host of debilitating conditions.
...may soon be available in over-the-counter gels and strips, according to a dental researcher who shared his team's latest findings today at the American Dental Association's national media conference.
Today, The Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a powerful demonstration of collective standing in the health care community, more than 40 organizations gathered on Capitol Hill to issue a call to action in reducing sudden cardiac arrest (SCA) deaths.
› Verified 5 days ago
Lala Ann Miner, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 730 Furnace St, Cumberland, MD 21502 Phone: 301-777-5941 | |
Connie Jo Morris, MSN, CRNP, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 925 Bishop Walsh Rd, Cumberland, MD 21502 Phone: 301-759-3800 Fax: 301-777-7455 | |
Landry Deuboue, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 157 Baltimore St, Cumberland, MD 21502 Phone: 240-727-3995 Fax: 833-903-0130 | |
Shannon Sprenkle, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 280, Cumberland, MD 21502 Phone: 240-964-8750 Fax: 240-964-8699 | |
Mrs. Beverly D. Tipton, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd Ste 640, Cumberland, MD 21502 Phone: 240-967-8717 | |
Jacob Mullan, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-8944 Fax: 240-964-8942 | |
Ashley Nicole Chucci, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd Ste 400, Cumberland, MD 21502 Phone: 240-964-8910 Fax: 240-964-8911 |